Alkem Laboratories is trading -0.17% lower at Rs 4,804.60 as compared to its last closing price. Alkem Laboratories has been trading in the price range of 4,823.10 & 4,776.00. Alkem Laboratories has given -14.57% in this year & -2.94% in the last 5 days. Alkem Laboratories has TTM P/E ratio 26.95 as compared to the sector P/E of 23.94.There are 17 analysts who have initiated coverage on Alkem Laboratories. There are 1 analysts who have given it a strong buy rating & 5 analysts have given it a buy rating. 4 analysts have given the stock a sell rating.The company posted a net profit of 305.86 Crores in its last quarter.Listed peers of Alkem Laboratories include Lupin (0.51%), Abbott India (-0.92%), Alkem Laboratories (-0.17%).The Mutual Fund holding in Alkem Laboratories was at 14.97% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Alkem Laboratories was at 9.40% in 31 Mar 2025. The FII holding has increased from the last quarter.
Updated on Jun 18, 2025, 10:36 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Lupin | Bearish | 1,953.45 | 0.51 | 89,213.18 | 28.05 | 5.34 | 0.40 | 11.80 |
Abbott India | Bullish | 31,510.00 | -0.92 | 66,963.61 | 47.59 | 15.9 | 1.50 | 3.73 |
Alkem Laboratories | Bearish | 4,804.60 | -0.17 | 57,596.39 | 26.88 | 4.86 | 0.92 | 4.83 |
Glaxosmithkline Pharmaceutical | Bullish | 3,277.35 | 0.77 | 55,765.48 | 61.72 | 29.23 | 1.25 | 0.13 |
Glenmark Pharmaceuticals | Bullish | 1,659.10 | 0.32 | 46,819.94 | 35.82 | 5.37 | 0.15 | 7.90 |
Meeting Date | Purpose |
---|---|
2025-05-29 | Audited Results & Final Dividend |
2025-02-07 | Quarterly Results & Interim Dividend |
2024-11-13 | Quarterly Results |
2024-08-09 | Quarterly Results |
2024-05-29 | Audited Results & Final Dividend |
Alkem Laboratories is trading at 4804.60 as on Wed Jun 18 2025 10:22:58. This is -0.17% lower as compared to its previous closing price of 4812.65.
The market capitalization of Alkem Laboratories is 57596.39 Cr as on Wed Jun 18 2025 10:22:58.
The average broker rating on Alkem Laboratories is Hold. The breakup of analyst rating is given below -
The 52 wk high for Alkem Laboratories is 6440.00 whereas the 52 wk low is 4498.90
Alkem Laboratories can be analyzed on the following key metrics -
Alkem Laboratories reported a net profit of 2165.48 Cr in 2025.
The Mutual Fund Shareholding was 14.97% at the end of 31 Mar 2025.